147 related articles for article (PubMed ID: 35848033)
21. Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study.
Yu H; Laberge L; Jaussent I; Bayard S; Scholtz S; Raoul M; Pages M; Dauvilliers Y
Sleep; 2011 Feb; 34(2):165-70. PubMed ID: 21286250
[TBL] [Abstract][Full Text] [Related]
22. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy.
Gibbs JW; Ciafaloni E; Radtke RA
Sleep; 2002 Sep; 25(6):662-5. PubMed ID: 12224846
[TBL] [Abstract][Full Text] [Related]
23. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
Talbot K; Stradling J; Crosby J; Hilton-Jones D
Neuromuscul Disord; 2003 Jun; 13(5):357-64. PubMed ID: 12798791
[TBL] [Abstract][Full Text] [Related]
24. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation.
Dauvilliers YA; Laberge L
Sleep Med Rev; 2012 Dec; 16(6):539-45. PubMed ID: 22465566
[TBL] [Abstract][Full Text] [Related]
25. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.
Annane D; Moore DH; Barnes PR; Miller RG
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD003218. PubMed ID: 16855999
[TBL] [Abstract][Full Text] [Related]
26. Sleep complaints in patients with myotonic dystrophy.
Laberge L; Bégin P; Montplaisir J; Mathieu J
J Sleep Res; 2004 Mar; 13(1):95-100. PubMed ID: 14996041
[TBL] [Abstract][Full Text] [Related]
27. [Sleep disorders and fatigue in patients with different forms of myotonic dystrophy type 1].
Erokhina EK; Melnik EA; Lebedeva DD; Shamtieva KV; Peters TV; Pavlikova EP; Gepard VV; Vlodavets DV
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(8):62-67. PubMed ID: 37655412
[TBL] [Abstract][Full Text] [Related]
28. Apathy and hypersomnia are common features of myotonic dystrophy.
Rubinsztein JS; Rubinsztein DC; Goodburn S; Holland AJ
J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):510-5. PubMed ID: 9576545
[TBL] [Abstract][Full Text] [Related]
29. A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1.
Laberge L; Bégin P; Dauvilliers Y; Beaudry M; Laforte M; Jean S; Mathieu J
J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):642-6. PubMed ID: 19211594
[TBL] [Abstract][Full Text] [Related]
30. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
Van Heugten C; Meuleman S; Hellebrekers D; Kruitwagen-van Reenen E; Visser-Meily J
J Neuromuscul Dis; 2018; 5(2):205-214. PubMed ID: 29865086
[TBL] [Abstract][Full Text] [Related]
31. Predictors of fatigue severity in early, de novo Parkinson disease patients: A 1-year longitudinal study.
Siciliano M; Trojano L; De Micco R; Giordano A; Russo A; Tedeschi G; Chiorri C; Tessitore A
Parkinsonism Relat Disord; 2020 Oct; 79():3-8. PubMed ID: 32853825
[TBL] [Abstract][Full Text] [Related]
32. Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2.
Lam EM; Shepard PW; St Louis EK; Dueffert LG; Slocumb N; McCarter SJ; Silber MH; Boeve BF; Olson EJ; Somers VK; Milone M
Neurology; 2013 Jul; 81(2):157-64. PubMed ID: 23749798
[TBL] [Abstract][Full Text] [Related]
33. Cognitive impairment and quality of life in patients with myotonic dystrophy type 1.
Fujino H; Shingaki H; Suwazono S; Ueda Y; Wada C; Nakayama T; Takahashi MP; Imura O; Matsumura T
Muscle Nerve; 2018 May; 57(5):742-748. PubMed ID: 29193182
[TBL] [Abstract][Full Text] [Related]
34. How to capture activities of daily living in myotonic dystrophy type 2?
Montagnese F; Rastelli E; Stahl K; Massa R; Schoser B
Neuromuscul Disord; 2020 Oct; 30(10):796-806. PubMed ID: 32888768
[TBL] [Abstract][Full Text] [Related]
35. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1).
Heatwole C; Bode R; Johnson N; Quinn C; Martens W; McDermott MP; Rothrock N; Thornton C; Vickrey B; Victorson D; Moxley R
Neurology; 2012 Jul; 79(4):348-57. PubMed ID: 22786587
[TBL] [Abstract][Full Text] [Related]
36. Fatigue in Parkinson's disease: concepts and clinical approach.
Nassif DV; Pereira JS
Psychogeriatrics; 2018 Mar; 18(2):143-150. PubMed ID: 29409156
[TBL] [Abstract][Full Text] [Related]
37. Reliability of the Apathy Evaluation Scale in Myotonic Dystrophy Type 1.
Gallais B; Gagnon C; Côté I; Forgues G; Laberge L
J Neuromuscul Dis; 2018; 5(1):39-46. PubMed ID: 29278897
[TBL] [Abstract][Full Text] [Related]
38. The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1.
Liguori C; Spanetta M; Fernandes M; Placidi F; Massa R; Romigi A; Izzi F; Mauro L; Greco G; Frezza E; Cattaneo F; Rubino A; Agostoni EC; Nobili L; Mercuri NB; Sansone VA; Proserpio P
Sleep Med; 2021 Dec; 88():134-139. PubMed ID: 34749272
[TBL] [Abstract][Full Text] [Related]
39. [Excessive daytime sleepiness, central type sleep apnea and myotonic dystrophy].
Reimão R; Lemmi H; Bertorini T
Arq Neuropsiquiatr; 1985 Dec; 43(4):391-5. PubMed ID: 3833140
[TBL] [Abstract][Full Text] [Related]
40. Affective symptoms and apathy in myotonic dystrophy type 1 a systematic review and meta-analysis.
van der Velden BG; Okkersen K; Kessels RP; Groenewoud J; van Engelen B; Knoop H; Raaphorst J
J Affect Disord; 2019 May; 250():260-269. PubMed ID: 30870776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
